Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$634,245
+$16,066 QoQ
Shares Held
4,047
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#789
of 1,603 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cannell & Spears LLC holds $208,924,357 across 12 Drug Manufacturers - General names. NVS ranks #9 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
557,332 | $71,617,162 | |
| 2 | ABBV |
AbbVie Inc.
|
255,977 | $64,414,052 | |
| 3 | JNJ |
Johnson & Johnson
|
169,381 | $43,017,692 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
236,705 | $13,638,942 | |
| 5 | PFE |
Pfizer Inc
|
236,223 | $5,688,249 | |
| 6 | LLY |
ELI LILLY & Co
|
3,814 | $4,574,626 | |
| 7 | AMGN |
Amgen Inc
|
8,507 | $3,080,554 | |
| 8 | BIIB |
Biogen Inc.
|
5,083 | $1,098,232 |
All Filings in NVS
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $634,245 | 4,047 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $618,179 | 4,047 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $704,239 | 5,108 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $462,689 | 3,608 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $337,133 | 2,786 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $309,691 | 2,778 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $539,583 | 5,545 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $676,087 | 5,878 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $686,879 | 6,452 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $582,991 | 6,027 | Shares | Sole | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||